PubMed Clinical Queries
This tool uses predefined filters to help you quickly refine PubMed searches on clinical or disease-specific topics. To use this tool, enter your search terms in the search bar and select filters before searching.
Results for Clinical Studies: Therapy/Broad
5 of 43 results sorted by: Most Recent
See all results in PubMed (43)-
Odevixibat (Bylvay): CADTH Reimbursement Recommendation: Indication: The treatment of pruritus in patients aged 6 months or older with progressive familial intrahepatic cholestasis [Internet].
[No authors listed] Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Mar. Report No.: SR0788. PMID: 38648297 Free Books & Documents. Review.
-
Management and outcomes after liver transplantation for progressive familial intrahepatic cholestasis: A systematic review and meta-analysis.
Kavallar AM, et al. Hepatol Commun. 2023. PMID: 37756114 Free PMC article.
-
Iterative antibody-induced bile salt export pump deficiency after successive liver transplantations successfully treated with plasmapheresis and rituximab.
Wischlen E, et al. Clin Res Hepatol Gastroenterol. 2023. PMID: 37187258
-
Clinical and genetic characterization of pediatric patients with progressive familial intrahepatic cholestasis type 3 (PFIC3): identification of 14 novel ABCB4 variants and review of the literatures.
Chen R, et al. Orphanet J Rare Dis. 2022. PMID: 36550572 Free PMC article. Review.
-
Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial.
Thompson RJ, et al. Lancet Gastroenterol Hepatol. 2022. PMID: 35780807 Free article. Clinical Trial.